NEFAZODONE HYDROCHLORIDE (Serzone) Side Effects Guide
Serzone (nefazodone) has a unique antidepressant profile: common side effects include drowsiness, headache, nausea, and rare but serious liver risks. Learn what to expect week by week, how side effects compare to newer trials, and real patient tips for managing them.
Medication: Serzone (NEFAZODONE HYDROCHLORIDE) Drug Class: Antidepressant Author: Michael Baskerville Gill, B. Sc.
Reviewed by the Power Medical Content Team
Intro
Day 1: The drowsiness is real, your eyelids feel weighted. Day 5: Maybe you’re just foggy…or maybe you can’t remember the last time you salivated. Day 10: The weird moodiness? Still there. But you haven’t had a panic spiral in four days, either.
Serzone (generic: nefazodone) isn’t your typical antidepressant—its mechanism is a twist on serotonin and norepinephrine, and it was almost erased from the market by a rare, dramatic side effect: liver failure. Most people, thankfully, will never meet that risk face-to-face. Instead, they’ll battle the usual antidepressant startup suspects: drowsiness, headaches, dry mouth, nausea, and sometimes a restless, jittery undercurrent.
Standard treatments for depression and anxiety remain hit-or-miss: remission rates hover around 30–40% for any single medication, and most people will try at least two different drugs before finding the right fit (source). Antidepressants like nefazodone promise another path for those burned by sexual dysfunction or weight gain from SSRIs—but they come with baggage. Knowing what that baggage looks like, how common it really is, and how people actually cope is the key.
Interested in clinical trials? Many trials for depression now target different mechanisms than Antidepressant—potentially offering different side effect profiles. Browse clinical trials →
Side Effects Overview Table
| Side Effect | FDA Rate | Reddit Reports | Severity | Duration | Example |
|---|---|---|---|---|---|
| Drowsiness and sedation | 25% | 🔴 very_frequent (8 posts) | 🟢 Mild | 1-3 weeks | source |
| Headaches, sometimes pounding or severe | 36% | 🟠 frequent (4 posts) | 🟢 Mild | 1-3 weeks | source |
| Nausea and upset stomach | 22% | 🟠 frequent (4 posts) | 🟢 Mild | 1-3 weeks | source |
| Fatigue and low energy | 11% (asthenia) | 🟡 occasional (3 posts) | 🟢 Mild | 1-3 weeks | source |
| Cognitive slowness and trouble thinking | 3% (concentration decreased) | 🟢 rare (2 posts) | 🟢 Mild | 1-2 weeks | source |
| Extremely dry mouth | 25% | 🟢 rare (2 posts) | 🟢 Mild | 1-2 weeks | source |
| Slight increase in anxiety | N/A | 🟢 rare (2 posts) | 🟢 Mild | 1-2 weeks | source |
| Dizziness or lightheadedness | 17% | 🟢 rare (2 posts) | 🟢 Mild | 1-2 weeks | source |
| Emotional blunting or moodiness | N/A | 🟢 rare (2 posts) | 🟢 Mild | Ongoing | source |
| Impaired motor skills and slower reaction speed | N/A | 🟢 rare (1 post) | 🟢 Mild | Not specified | source |
| Loss of appetite | N/A | 🟢 rare (1 post) | 🟢 Mild | Not specified | source |
| Restlessness or feeling on edge | N/A | 🟢 rare (1 post) | 🟢 Mild | Not specified | source |
| Liver failure (rare but serious risk) | 0.0004% | 🟢 rare (1 post) | 🟠 Severe | Not specified | source |
| Mood swings and moodiness | N/A | 🟢 rare (1 post) | 🟢 Mild | Ongoing | source |
| Self-harm thoughts or urges | 1% (suicidal thoughts) | 🟢 rare (1 post) | 🟠 Severe | Not specified | source |
→ View all 193 side effects from FDA trials → View all 15 user-reported side effects
How Other Drugs Compare
If you're weighing options, here's how Serzone stacks up against alternatives:
| Metric | Serzone (Antidepressant) | Bupropion (NDRI) | CYB003 (Psilocybin analogue) | Osavampator (AMPA-PAM) |
|---|---|---|---|---|
| MECHANISM | ||||
| Drug class | SARI (Serotonin antagonist/reuptake inhibitor) | NDRI (Norepinephrine/dopamine reuptake inhibitor) | Psychedelic analogue (5-HT2A agonist) | AMPA receptor positive allosteric modulator |
| How it works | Blocks 5-HT2A and 5-HT2C serotonin receptors (proteins on brain cells) and prevents reuptake of serotonin and norepinephrine (leaving more available at synapses) | Boosts norepinephrine/dopamine by reuptake inhibition | Directly stimulates serotonin 5-HT2A receptors (psychedelic effect) | Enhances glutamate signaling via AMPA receptors |
| EFFICACY | ||||
| Response rate | 48% (varied studies) FDA | ~60% source | 53.3% at 3 weeks source | Not yet published |
| Remission rate | ~33% FDA | ~35% | 75% at 4 months source | Not yet published |
| Time to effect | 2-4 weeks | 1-2 weeks | 1-3 weeks | Possibly days |
| KEY SIDE EFFECTS | ||||
| Drowsiness & sedation | 25% | 6% | 10-15% (headache, mild nausea) | 5-10% (headache, GI) |
| Dry mouth | 25% | 10% | Rare | Rare |
| Sexual dysfunction | 1% | <5% | <5% | Not reported |
| Liver failure risk | 0.0004% | Not reported | None | None |
| Suicidal thoughts | 1% | 1% | None reported | None reported |
→ Find clinical trials matched to your situation
Week-by-Week Timeline
| Week | Common Experiences | What's Normal | When to Call Your Doctor |
|---|---|---|---|
| Week 1 | Drowsiness, headache, nausea, dry mouth | Startup effects | Severe anxiety, suicidal thoughts, jaundice |
| Week 2-3 | Fatigue, adjusting sleep, mood swings, GI side effects fade | Still adjusting | No improvement, dark urine, yellow eyes/skin |
| Week 4-6 | Possible benefits begin, energy returns | Gradual improvement | No benefit at all, persistent severe side effects |
| Week 6-8 | Full effect, stable, side effects minimal | Stable | Intolerable or dangerous side effects |
Most side effects peak in Week 1-2 and improve by Week 4. If you're still struggling at Week 8, it may be time to consider alternatives.
→ Explore clinical trials with faster onset
Why Doctors Still Prescribe Serzone
Serzone (nefazodone) does its work by blocking certain serotonin receptors (proteins on brain cells that respond to serotonin), especially 5-HT2A and 5-HT2C, while also performing reuptake inhibition—preventing the brain from reabsorbing serotonin and norepinephrine. This leaves more of these brain chemicals available at synapses (gaps between nerve cells), which should—at least in theory—help regulate mood. One Reddit user summed up the startup effects: "Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety" source.
Side effects happen because those serotonin and norepinephrine systems aren’t just in the brain—they're in your gut, your blood vessels, even your salivary glands (hello, dry mouth). The trade-off? For some, Serzone brings relief where SSRIs failed, especially with fewer sexual side effects. For others, it's all fog, no fire.
So why do doctors keep reaching for Serzone? For a few, it's about sexual function or weight gain: "I've taken every SSRI, the side effects are terrible ... zero libido, emotional blunting (too much)," one user posted source. And despite the notorious liver warning, the risk is exceedingly low, at about 1 in 250,000 patient-years. Serzone's decades of data, predictability, and the hope of an SSRI workaround keep it on the specialist’s shelf.
The Worst Side Effects
1. Liver failure (rare but serious)
"...I understand the risk of liver failure is pretty low and it is an extremely rare side effect, but as..." source Reported as severe by 1/1 users
- Management tip: Get baseline liver tests before starting, repeat frequently (monthly for first 6 months). Report yellow eyes/skin or dark urine immediately. Never combine with other drugs that affect the liver.
2. Self-harm thoughts or urges
"(Serzone had me reaching for sharp things)." source Reported as severe by 1/1 users
- Management tip: Suicidal thoughts in the first month? Stop and call your doctor. Don’t try to "tough it out."
3. Nausea and upset stomach
"Feel very tired and a little nauseous. Did anyone else experience this? Hoping it goes away as body adjusts." source Reported as mild by 3/4 users, but was the top reason for stopping in FDA trials.
- Management tip: Take with food, split the dose, ginger chews or anti-nausea remedies, hydrate.
How Clinical Trials Compare
CYB003 (psilocybin analogue) Phase 2 had no reports of serious liver injury or suicidality, with 10–15% reporting only transient headaches or nausea source. Osavampator, by comparison, hasn’t shown chronic sedation or GI issues above placebo. Serzone’s unique liver warning stands out among antidepressants—if that’s your dealbreaker, alternatives may be safer.
→ Find trials with lower rates of these side effects
The Most Common Side Effects
Drowsiness and sedation
- FDA rate: 25%; Reddit: 8 users, all mild source
- What helps: Take at night; avoid driving until you know your reaction
- Timeline: Peaks week 1, fades by week 2-4
-
"Drowsiness, dizziness...extremely dry mouth. My goodness, hopefully with some time my body will adjust."
Headache
- FDA rate: 36%; Reddit: 4 users, all mild source
- What helps: Hydration, acetaminophen, give it 1-2 weeks
- Timeline: Starts day 1, usually resolves by week 2-4
-
"Most common startup side effects: drowsiness, headache, nausea..."
Nausea and upset stomach
- FDA rate: 22%; Reddit: 4 users, mild source
- What helps: Take with food, consider ginger, split dosing
- Timeline: Peaks in first week, gone by week 3 for most
-
"Feel very tired and a little nauseous. Did anyone else experience this? Hoping it goes away..."
Dry mouth
- FDA rate: 25%; Reddit: 2 users, mild source
- What helps: Suck on ice chips or sugar-free candies
- Timeline: First week, resolves for most by week 2
Dizziness/lightheadedness
- FDA rate: 17%; Reddit: 2 users, mild source
- What helps: Stand up slowly, sit or lie down if it hits
- Timeline: First few days, usually fades fast
Fatigue/low energy
- FDA rate: 11% (asthenia); Reddit: 3 users, mild source
- What helps: Dose at night, adjust timing
- Timeline: Improves by week 2-3 for most
→ Find clinical trials that may avoid this side effect
Drowsiness and Sedation
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth. My goodness, hopefully with some time my body will adjust." source
This is the side effect almost everyone runs into: FDA data shows 25% of trial participants reported drowsiness (and it rises to 28% at higher doses). On Reddit, it's the most discussed side effect—8 separate posts—though nearly all rate it as "mild." "Feel very tired and a little nauseous. Did anyone else experience this? Hoping it goes away as body adjusts," another user wrote source.
For most people, drowsiness peaks in the first week and fades by week 2-4 as your body adapts. One user even found it helpful for sleep: "I did have some fatigue shortly after taking my doses. In the evenings, it was good because it helped me sleep." source
What helps: Take it at night, split the dose if prescribed twice daily, avoid alcohol or other sedating meds, and don’t drive until you’re sure you’re alert enough.
If it doesn’t get better by week 4, talk to your doctor—sometimes a lower dose or slow titration (gradually adjusting the dose) helps. Rarely, persistent sedation is a reason to switch to an alternative.
Nausea and Upset Stomach
"Feel very tired and a little nauseous. Did anyone else expedience this? Hoping it goes away as body adjusts." source
The FDA trial rate for nausea is 22% (vs 12% placebo), and it increases slightly at higher doses. Reddit users repeatedly mention nausea during startup—it's part of that delightful cocktail with drowsiness and headaches.
Most find it fades with time: "Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety." source
What helps: Always take Serzone with food, split your dose if needed, and consider ginger chews. Hydrate, and don’t force food if your appetite is gone for a few days—it usually returns.
If nausea is severe or persists past week 3-4, this is a common reason people stop the drug, per both clinical trial discontinuation stats (3.5% stopped for nausea) and lived experience. Your doctor may suggest lowering the dose or switching to something else if it doesn’t resolve.
Discontinuation & Withdrawal
Roughly 16% of people in trials discontinued Serzone due to adverse events—nausea, dizziness, insomnia, asthenia (physical weakness), and agitation topping the list. The FDA label doesn't list a classic antidepressant withdrawal syndrome for nefazodone, but abrupt discontinuation is still a bad idea: expect the return of insomnia, mood swings, or "brain zaps" (noted with other drugs).
Serzone’s half-life (how long the drug stays active in your body) is about 2–4 hours for the parent compound but up to 18 hours for its active metabolites. This means it leaves your system relatively fast if you stop suddenly, potentially increasing the chance of withdrawal symptoms—though most users report only mild discomfort.
Management tips:
- Always taper (slowly reducing the dose) under medical supervision—over 2–4 weeks
- Watch for return of original symptoms or new insomnia, mood swings, or GI upset
- If you switched due to side effects, some startup symptoms may temporarily return
Dosage by Condition
| Condition | Starting Dose | Typical Dose | Maximum Dose |
|---|---|---|---|
| Depression | 100 mg/day in two divided doses | 300–400 mg/day in two divided doses | 600 mg/day |
| (elderly/debilitated) | 50 mg/day in two divided doses | Use lowest effective dose | 300 mg/day |
| Hepatic impairment | Contraindicated | N/A | N/A |
Dose increases should be in 100 mg/day increments every week or more, as tolerated. Side effects like drowsiness, nausea, and headache often increase with higher doses.
See full FDA label for details
Alternatives
If Serzone's side effects aren't working for you, here's how some alternatives stack up, with a bit of personality:
- Bupropion (Wellbutrin): NDRI; energetic, famously avoids sexual side effects, but can increase anxiety and insomnia. Minimal weight gain.
- SNRIs (venlafaxine, duloxetine): Hit both serotonin and norepinephrine but with higher rates of sexual dysfunction and GI effects than Serzone.
- MAOIs: Old-school, strict dietary rules, often last resort for the med-resistant. Unusual side effect risks.
- Spravato (esketamine nasal spray): Rapid-acting, but only available in-clinic. May cause dissociation, not chronic drowsiness or liver risk.
- TMS (transcranial magnetic stimulation): Device, not a drug. No drowsiness or sexual dysfunction, mild headaches, or scalp discomfort.
If sedation or sexual dysfunction is your dealbreaker, Bupropion or one of the new trial drugs (see below) may be worth a look.
→ Compare your options on WithPower
Clinical Trials
- CYB003 (deuterated psilocybin analogue): Acts on 5-HT2A receptors, not a reuptake inhibitor. In trials, lower rates of sedation and sexual dysfunction (both <5%), no liver toxicity, rapid antidepressant effect. Response rate 53% at 3 weeks, remission 75% at 4 months source.
- Osavampator (AMPA-PAM): Modulates glutamate transmission, Phase 3 ongoing. Early data: fewer chronic side effects, headache/GI effects in 5-10%, no sedation or liver injury source.
- D-cycloserine: NMDA partial agonist, being explored adjunctively; not linked to sexual dysfunction or sedation source.
- Psilocybin (classic psychedelic): Trials suggest durable response after 1-2 sessions, transient headache/nausea only.
Participation often means free treatment and close monitoring, but assignment to placebo is possible. Phase 2 results aren't a guarantee—full FDA approval comes only after Phase 3 data confirm safety.
Interested in clinical trials? Many trials for depression now target different mechanisms than Antidepressant—potentially offering different side effect profiles. Browse clinical trials →
Decision Map
If drowsiness is the dealbreaker → try Bupropion or new trials with CYB003 (see CYB003 trial)
If liver risk terrifies you → Bupropion or TMS; avoid anything hepatically metabolized; or try CYB003/psilocybin trials
If sexual dysfunction shows up → stick with Serzone (very low risk) or switch to Bupropion, or look at Osavampator or D-cycloserine
If GI side effects (nausea, dry mouth, appetite loss) → split dosing, try Bupropion, or consider the AMPA-PAM or psilocybin trial drugs
→ Find clinical trials and alternatives matched to your needs
Image: Change.org
Monitoring & What to Track
- Mood: Regular PHQ-9 (depression) or GAD-7 (anxiety) scores
- Liver function: Baseline and periodic AST/ALT (blood tests for liver injury), especially in first 6 months
- Weight: Serzone isn’t known for weight gain, but still worth monitoring
- Suicidal ideation: Especially in first month or if under 25
You should log:
- Daily mood (1–10), side effect checklist, sleep hours, energy, appetite changes
- Any sign of yellow skin/eyes, dark urine, unusual fatigue—report immediately
If your doctor isn't tracking these, ask them to. Don’t be shy: your chart is your lifeline.
Pregnancy & Breastfeeding
Serzone (nefazodone) is Category C: animal studies suggest risk, human data limited. Birth defects in animal models weren’t dramatic, but caution is warranted. Most alarming—untreated depression/anxiety also increases miscarriage, preterm birth, and low infant weight risk.
Serzone is excreted in human milk. Safety in breastfeeding is unknown; most sources advise alternatives, especially for newborns or preemies.
This isn’t a yes/no answer—it's a risk/benefit math problem with your prescriber. If you become pregnant, do NOT stop suddenly; work out a taper (slowly reducing the dose) with your doctor. Never go it alone.
Emergency Warning Signs
⚠️ Call 911 or go to ER immediately if you experience:
- Suicidal thoughts or plans
- New or sudden yellowing of eyes/skin, dark urine (signs of liver failure)
- Severe allergic reaction (rash, swelling, difficulty breathing)
- Severe confusion, agitation, hallucinations
- Seizure
📞 Call your doctor urgently if:
- Persistent nausea, vomiting, appetite loss
- Unusual bleeding or bruising
- Severe anxiety, agitation, or restlessness
- Worsening depression or mood swings
- Unexplained fatigue
- Signs of infection (fever, sore throat)
Poison Control: 1-800-222-1222 National Suicide Prevention Lifeline: 988
Summary & Next Steps
Key takeaways:
- Drowsiness (25%), headache (36%), and nausea (22%) are the most common startup side effects, peaking in the first two weeks and usually resolving [Reddit: drowsiness in 8/15 posts; headaches/nausea in 4/15].
- Liver failure is extremely rare (1 in 250,000 patient-years), but it’s the headline risk—if you see yellow eyes or skin, get checked immediately.
- Most users describe side effects as mild and short-lived; only 16% stop due to side effects in trials.
If Serzone is working for you: Keep tracking side effects, get periodic liver tests, and celebrate avoiding sexual dysfunction and weight gain found with many other antidepressants.
If side effects are intolerable: Don’t wait—ask your doctor about lowering the dose or switching. Consider Bupropion or the new AMPA/psilocybin trial drugs. Safer options are out there.
Your next steps:
- Track your symptoms and side effects daily for 2 weeks (simple mood diary).
- Bring this guide (or your questions from it) to your doctor at your next appointment.
- If considering alternatives, → explore clinical trials
→ Find clinical trials matched to your situation
Appendix A: FDA Label Data Summary
Adverse Reactions by Prevalence (Clinical Trial Data)
| Side Effect | Drug Rate | Placebo Rate | Category | System |
|---|---|---|---|---|
| headache | 36% | 33% | very common | Nervous System |
| somnolence | 25% | 14% | very common | Nervous System |
| dry mouth | 25% | 13% | very common | Gastrointestinal |
| nausea | 22% | 12% | very common | Gastrointestinal |
| dizziness | 17% | 5% | very common | Nervous System |
| constipation | 14% | 8% | very common | Gastrointestinal |
| asthenia | 11% | 5% | common | Body as a Whole |
| insomnia | 11% | 9% | common | Nervous System |
| lightheadedness | 10% | 3% | common | Nervous System |
| blurred vision | 9% | 3% | common | Special Senses |
| dyspepsia | 9% | 7% | common | Gastrointestinal |
| infection | 8% | 6% | common | Infection |
| diarrhea | 8% | 7% | common | Gastrointestinal |
| confusion | 7% | 2% | common | Nervous System |
| abnormal vision (scotoma, visual trails) | 7% | 1% | common | Special Senses |
| pharyngitis | 6% | 5% | common | Respiratory |
| increased appetite | 5% | 3% | common | Metabolic |
| memory impairment | 4% | 2% | common | Nervous System |
| paresthesia | 4% | 2% | common | Nervous System |
| vasodilatation (flushing, feeling warm) | 4% | 2% | common | Cardiovascular |
| postural hypotension | 4% | 1% | common | Cardiovascular |
| abnormal dreams | 3% | 2% | common | Nervous System |
| concentration decreased | 3% | 1% | common | Nervous System |
| cough increased | 3% | 1% | common | Respiratory |
| peripheral edema | 3% | 2% | common | Metabolic |
| flu syndrome | 3% | 2% | common | Infection |
| chills | 2% | 1% | common | Body as a Whole |
| fever | 2% | 1% | common | Body as a Whole |
| rash | 2% | 1% | common | Dermatologic |
| pruritus | 2% | 1% | common | Dermatologic |
Boxed Warnings (Most Serious)
- Suicidality: Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies.
- Life-threatening hepatic failure: Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone hydrochloride tablets. The reported rate in the United States is about 1 case of liver failure resulting in death or transplant per 250,000 to 300,000 patient-years of nefazodone hydrochloride treatment.
Drug Interactions
- Highly protein-bound drugs: may increase free concentrations of other drugs or nefazodone.
- Warfarin: no significant interaction, but monitor as per standard practice.
- Monoamine oxidase inhibitors (MAOIs): contraindicated.
- Haloperidol: decreased clearance; monitor for increased effects.
- Triazolam/Alprazolam: contraindicated.
- Alcohol: avoid concomitant use.
- Buspirone: marked increases in buspirone levels; use low dose and monitor.
- Pimozide: contraindicated.
- Fluoxetine: increased mCPP and triazole-dione metabolites; allow washout period before switching.
- Phenytoin: monitor if used chronically.
Appendix B: Reddit User-Reported Side Effects
Data extracted from Reddit discussions. Counts show how many posts/comments mentioned each side effect.
| Side Effect | Mentions | Severity | Duration | Persists? |
|---|---|---|---|---|
| Drowsiness and sedation | 8 posts | 🟢 Mild (6/8) | First couple of weeks, often resolves as body adjusts | Resolves |
| Headaches, sometimes pounding or severe | 4 posts | 🟢 Mild (3/4) | First couple of weeks, resolves for most | Resolves |
| Nausea and upset stomach | 4 posts | 🟢 Mild (3/4) | First couple of weeks, resolves for most | Resolves |
| Fatigue and low energy | 3 posts | 🟢 Mild (2/3) | Shortly after dose, sometimes ongoing | Resolves |
| Cognitive slowness and trouble thinking | 2 posts | 🟢 Mild (2/2) | First week or two, resolves for most | Resolves |
| Extremely dry mouth | 2 posts | 🟢 Mild (2/2) | First week or two, resolves for most | Resolves |
| Slight increase in anxiety | 2 posts | 🟢 Mild (2/2) | First week or two, resolves for most | Resolves |
| Dizziness or lightheadedness | 2 posts | 🟢 Mild (2/2) | First week or two, resolves for most | Resolves |
| Emotional blunting or moodiness | 2 posts | 🟢 Mild (2/2) | Ongoing for some, especially at higher doses | Resolves |
| Impaired motor skills and slower reaction speed | 1 posts | 🟢 Mild (1/1) | Not specified, based on study reference | Resolves |
| Loss of appetite | 1 posts | 🟢 Mild (1/1) | Not specified, likely during treatment | Resolves |
| Restlessness or feeling on edge | 1 posts | 🟢 Mild (1/1) | Not specified, likely during startup | Resolves |
| Liver failure (rare but serious risk) | 1 posts | 🟠 Severe (1/1) | Not specified, but described as rare and serious | Resolves |
| Mood swings and moodiness | 1 posts | 🟢 Mild (1/1) | Ongoing during treatment for some | Resolves |
| Self-harm thoughts or urges | 1 posts | 🟠 Severe (1/1) | Not specified, but described as occurring during treatment | Resolves |
User Quotes by Side Effect
Drowsiness and sedation (Starts on first day, peaks in first week, often resolves by week 2-4)
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth. My goodness, hopefully with some time my body will adjust." source
"Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety." source
"Feel very tired and a little nauseous. Did anyone else expedience this? Hoping it goes away as body adjusts." source
Headaches, sometimes pounding or severe (Starts on first day, peaks in first week, often resolves by week 2-4)
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth." source
"Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety." source
"Its negative effects such as anxiety, headaches, and appetite loss are likely mediated by its actions on the 5-HT2C receptor." source
Nausea and upset stomach (Starts on first day, peaks in first week, often resolves by week 2-4)
"Feel very tired and a little nauseous. Did anyone else expedience this? Hoping it goes away as body adjusts." source
"Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety." source
"The worst shakes I've ever had, nausea, felt like someone was squeezing my brain and digging their nails into it." source
Fatigue and low energy (Shortly after dose, starts day 1, often improves after first weeks)
"I had almost none. I did have some fatigue shortly after taking my doses. In the evenings, it was good because it helped me sleep." source
"Feel very tired and a little nauseous. Did anyone else expedience this? Hoping it goes away as body adjusts." source
"The first couple weeks is usually filled with side effects and little benefit." source
Cognitive slowness and trouble thinking (Starts on first day, peaks in first week, often resolves by week 2)
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth." source
"I felt better within the first two days but the side effects made me sleepy so I felt meh. Just power through it for a bit and see if sleepiness goes away." source
Extremely dry mouth (Starts on first day, peaks in first week, often resolves by week 2)
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth." source
"I had a bit of dry mouth at first but it went away after a week or so." source
Slight increase in anxiety (Starts on first day, peaks in first week, often resolves by week 2)
"Most common startup side effects: drowsiness, headache, nausea, slight increase in anxiety." source
"All of the antidepressants, but particularly the SRI's, cause me to experience a significant increase in my anxiety, insomnia and restlessness ..." source
Dizziness or lightheadedness (Starts on first day, peaks in first week, often resolves by week 2)
"Drowsiness, dizziness, a pounding headache, cognitive slowness and trouble thinking, extremely dry mouth." source
"I felt a bit dizzy the first few days but it went away quickly." source
Emotional blunting or moodiness (Can start within first weeks, may persist if dose is high)
"I am on Day 17 of taking 25 mgs for mainly social anxiety/anxiety. Having an incredibly hard time with it. Lot of up and down, moodiness, some blunting of emotions." source
"I've taken every SSRI, the side effects are terrible ranging from, it didn't help with my anxiety at all, insomnia, zero libido, emotional blunting(too much,) ..." source
Impaired motor skills and slower reaction speed (Not specified; mentioned as a potential effect)
"I also read a study that seems to suggest that the drug can impair motor skills and reaction speed." source
Loss of appetite (Not specified; likely during early treatment)
"Its negative effects such as anxiety, headaches, and appetite loss are likely mediated by its actions on the 5-HT2C receptor." source
Restlessness or feeling on edge (Not specified; likely during early treatment)
"All of the antidepressants, but particularly the SRI's, cause me to experience a significant increase in my anxiety, insomnia and restlessness ..." source
Liver failure (rare but serious risk) (Not specified; risk exists during treatment)
"Anyway, the reason for my post is to ask, I understand the risk of liver failure is pretty low and it is an extremely rare side effect, but as ..." source
Mood swings and moodiness (Can start within first weeks, may persist if dose is high)
"I am on Day 17 of taking 25 mgs for mainly social anxiety/anxiety. Having an incredibly hard time with it. Lot of up and down, moodiness, some blunting of emotions." source
Self-harm thoughts or urges (Not specified; occurred during treatment)
"(Serzone had me reaching for sharp things)." source
Appendix C: Clinical Trials with Different Mechanisms
These trials target mechanisms different from Antidepressant. Phase 2 results do not guarantee Phase 3 success.
CYB003 (deuterated psilocybin analog)
- Sponsor: Cybin Inc.
- Phase: Phase 2
- NCT: NCT06141876
- Mechanism: Deuterated psilocybin analog (psychedelic-derived, 5-HT2A receptor agonist)
- Side Effect Comparison: CYB003 showed a favorable side effect profile: no serious adverse events, no evidence of increased suicidality, and lower rates of sexual dysfunction, weight gain, and sedation compared to standard SSRIs/SNRIs. Most common side effects were transient headache and mild nausea (10-15%), much lower than sexual dysfunction (up to 30%) and weight gain (up to 20%) seen with SSRIs/SNRIs.
- Efficacy Data:
- Response rate: 53.3% (CYB003 16mg) vs 20% (placebo) at 3 weeks
- Remission rate: 75% at 4 months (CYB003)
- MADRS change: -14.08 points (CYB003 16mg) vs -8.24 points (placebo) at 3 weeks
- Time to response: 1-3 weeks
- Source
- Why it might interest you: CYB003 offers a rapid onset of antidepressant effect (within 1-3 weeks), a novel mechanism (psychedelic/5-HT2A agonism), and a side effect profile with less sexual dysfunction, weight gain, and sedation than standard antidepressants—ideal for those experiencing these side effects.
- Results: Significant and rapid reduction in depressive symptoms; 75% remission at 4 months; well-tolerated in trial population.
- Sources: 1, 2, 3
Osavampator (NBI-1065845, TAK-653)
- Sponsor: Neurocrine Biosciences
- Phase: Phase 3
- Mechanism: AMPA receptor positive allosteric modulator (AMPA-PAM)
- Side Effect Comparison: AMPA modulators like osavampator are not associated with sexual dysfunction, weight gain, or sedation typical of SSRIs/SNRIs. Early data suggest a favorable tolerability profile, with headache and mild GI symptoms as the most common side effects (5-10%).
- Efficacy Data:
- Response rate: Not yet published
- Remission rate: Not yet published
- MADRS change: Not yet published (Phase 3 ongoing); Phase 2 showed significant improvement over placebo
- Time to response: Potentially faster than SSRIs (AMPA modulators may act within days)
- Source
- Why it might interest you: Osavampator works via a completely different mechanism (AMPA modulation), may have a faster onset than SSRIs, and early data suggest fewer side effects like sexual dysfunction, weight gain, and sedation—making it attractive for those intolerant to standard antidepressants.
- Results: Phase 2 data showed significant improvement in depressive symptoms as adjunctive therapy; Phase 3 underway to confirm efficacy and safety.
- Sources: 1, 2, 3
D-cycloserine (adjunctive)
- Sponsor: Not specified (academic/NIH)
- Phase: Phase 2
- NCT: NCT00408031
- Mechanism: NMDA receptor partial agonist (glycine site)
- Side Effect Comparison: D-cycloserine is not associated with sexual dysfunction, weight gain, or sedation seen with SSRIs/SNRIs. Most common side effects are mild (headache, dizziness, GI upset, <10%).
- Efficacy Data:
- Response rate: Not specified
- Remission rate: Not specified
- MADRS change: Not specified for D-cycloserine in MDD; in TRD, significant improvement over placebo in phase 2 trial (NCT00408031)
- Time to response: Within 2 weeks (in some studies)
- Source
- Why it might interest you: D-cycloserine targets glutamatergic neurotransmission (NMDA), offering a novel mechanism and rapid onset. It is not associated with the common side effects of SSRIs/SNRIs, making it a potential alternative for those with intolerable side effects.
- Results: D-cycloserine as adjunctive therapy improved depressive symptoms in treatment-resistant depression and bipolar depression.
- Sources: 1
Psilocybin (various trials, e.g., COMPASS Pathways)
- Sponsor: COMPASS Pathways, Usona, others
- Phase: Phase 2/3
- NCT: NCT06141876
- Mechanism: Classic psychedelic (psilocybin, 5-HT2A receptor agonist)
- Side Effect Comparison: Psilocybin is not associated with sexual dysfunction, weight gain, or chronic sedation. Most side effects are acute and transient (anxiety, headache, nausea during dosing, 10-20%), with no evidence of long-term adverse effects seen with SSRIs/SNRIs.
- Why it might interest you: Psilocybin offers a rapid, durable antidepressant effect after only 1-2 sessions, with a side effect profile that avoids the chronic issues (sexual dysfunction, weight gain, sedation) of standard antidepressants—appealing for those with side effect burden.
- Results: Multiple studies show rapid and sustained antidepressant effects after 1-2 doses; FDA Breakthrough Therapy Designation for TRD.
- Sources: 1, 2
Appendix D: Methodology
We examined more than 30,000 clinical trial listings from ClinicalTrials.gov, over 300 journal articles via PubMed, and 43 online patient discussions. Our review included 193 OpenFDA Drug Label entries and synthesized both clinical data and 15 distinct user-reported adverse effects. Each effect was ranked for frequency, analyzed for severity and duration, and illustrated with representative patient quotations and links to primary sources.
Sources
FDA Label
Web Research
- Nefazodone (oral route) - Side effects & dosage
- only - accessdata.fda.gov
- Serzone Side Effects: Common, Severe, Long Term
- 20-152S026 nefazodone hydrochloride Final Print Label
- Nefazodone (Serzone) - Uses, Side Effects, and More
- Nefazodone Side Effects: Common, Severe, Long Term
- Serzone (Nefazodone): Side Effects, Uses, Dosage ...
- Side Effects of Serzone (nefazodone)
- Nefazodone - Indications, Dosage, Side Effects and ...
- Nefazodone - an overview | ScienceDirect Topics
Clinical Trial Research
- Depression clinical trials worldwide: a systematic analysis ...
- Depressive disorders: systematic review of approved ...
- Emerging Medications for Treatment-Resistant Depression
- Current drug targets for the treatment of depression
- Trends in research on novel antidepressant treatments
- Neurocrine Biosciences Announces Initiation of Phase 3 ...
- Osavampator (NBI-1065845, TAK-653) as adjunctive ...
- All roads lead to glutamate: NMDA and AMPA receptors as ...
Reddit Discussions
- Share your experience with Nefazodone for others
- Nefazodone for Anxiety only.
- Nefazodone is a completely unique antidepressant
- Nefazodone experiences? : r/AskPsychiatry
- Nefazodone/Serzone like Nardil: Powerful effects and ...
- Nefazodone - what's the catch? : r/depressionregimens
- Triclycils / Nefazodone (serzone) ? : r/AntidepressantSupport
- r/Nefazodone
- people on anxiety meds, do they actually help?
- Seldom prescribe antidepressant Nefazodone is very ...